TABLE 14: Treatment - chemotherapy

% of Cases treated with Chemotherapy
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 26.0% 25.3% 26.3% 23.4% - 26.2%
All xnmsc 0-24 63.3% 61.9% 63.4% 63.7% - 58.5%
All xnmsc 25-59 39.2% 40.3% 39.0% 39.7% - 42.1%
All xnmsc 60-79 26.7% 25.5% 27.2% 22.5% - 26.9%
All xnmsc 80+ 8.4% 7.7% 8.7% 5.6% - 8.8%
Haematology 52.7% 53.3% 52.5% 54.9% - 52.6%
Head and Neck 29.5% 30.2% 29.7% 24.4% - 36.6%
Lower GI 33.7% 33.1% 34.1% 29.7% - 35.4%
Upper GI 40.5% 38.4% 41.3% 33.2% - 40.6%
HPB 25.4% 21.8% 26.6% 15.5% - 23.4%
Trachea, Bronchus & Lung 25.9% 24.1% 26.8% 19.1% - 26.2%
Melanoma of skin 1.3% 1.3% 1.4% 0.2% - 2.3%
Breast 30.9% 30.4% 31.1% 28.5% - 31.6%
Cervix 37.1% 39.1% 36.5% 39.5% - 41.4%
Other Female Genitals 28.9% 28.1% 29.0% 28.7% - 26.5%
Prostate 6.7% 6.9% 6.7% 8.0% - 6.1%
Kidney 8.7% 9.0% 9.0% 3.7% - 14.3%
Bladder 32.1% 28.8% 33.1% 24.2% - 29.1%
Brain and CNS 38.3% 37.0% 38.6% 37.4% - 35.2%
Thyroid & other endocrine glands 3.7% 7.7% 3.0% 5.7% - 14.6%
CUP 10.4% 9.1% 10.9% 6.7% - 9.6%
Other invasive cancer 29.9% 30.1% 29.9% 30.6% - 29.8%
Breast in situ 1.9% 1.5% 2.0% 1.3% - 1.3%
Cervix in situ 0.0% 0.0% 0.0% 0.0% - 0.0%
Other tumours 15.0% 12.7% 15.6% 13.1% - 9.3%
Non-Melanoma Skin Cancer 0.1% 0.3% 0.1% 0.7% - 0.1%